admin,  —

Chris Comish serves as the Publisher of the website, and is responsible for directing the editorial focus as well as putting the finishing touches on many featured articles.

Articles by

Recorlev Developer Strongbridge Secures $53 Million in Financing

Strongbridge Biopharma has entered into an agreement for $50 million in credit and $3 million in equity investment with the healthcare-focused firm CRG to meet the demand for Keveyis (dichlorphenamide) and advance the development of its major therapeutic candidate Recorlev (levoketoconazole). Recorlev is an investigational cortisol synthesis inhibitor under development for the…